These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26343216)

  • 1. Universal cholesterol screening of children in community-based ambulatory pediatric clinics.
    Wilson DP; Davis S; Matches S; Shah D; Leung-Pineda V; Mou M; Hamilton L; McNeal CJ; Bowman WP
    J Clin Lipidol; 2015; 9(5 Suppl):S88-92. PubMed ID: 26343216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric cholesterol screening practices in 9- to 11-year-olds in a large midwestern primary care setting.
    Allen-Tice C; Steinberger J; Murdy K; Zierhut H
    J Clin Lipidol; 2020; 14(2):224-230. PubMed ID: 32111582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on screening, etiology, and treatment of dyslipidemia in children.
    Bamba V
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3093-102. PubMed ID: 24848708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges to implementing the current pediatric cholesterol screening guidelines into practice.
    Dennison BA; Jenkins PL; Pearson TA
    Pediatrics; 1994 Sep; 94(3):296-302. PubMed ID: 8065853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point: The rationale for universal lipid screening and treatment in children.
    Benuck I
    J Clin Lipidol; 2015; 9(5 Suppl):S93-S100. PubMed ID: 26343217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are parents' self-reported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guidelines.
    Resnicow K; Cross D
    Pediatrics; 1993 Sep; 92(3):347-53. PubMed ID: 8361788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs?
    Lipshultz SE; Schaechter J; Carrillo A; Sanchez J; Qureshi MY; Messiah SE; Hershorin ER; Wilkinson JD; Miller TL
    Pediatr Endocrinol Rev; 2012 Aug; 9(4):698-705. PubMed ID: 23304806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of implementation of the Clinical Laboratory Improvement Amendments of 1988--the example of pediatric office-based cholesterol screening.
    Tershakovec AM; Brannon SD; Bennett MJ; Shannon BM
    Pediatrics; 1995 Aug; 96(2 Pt 1):230-4. PubMed ID: 7630675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary risk factors in adolescents related to their knowledge of familial coronary heart disease and hypercholesterolemia: the Muscatine Study.
    Muhonen LE; Burns TL; Nelson RP; Lauer RM
    Pediatrics; 1994 Mar; 93(3):444-51. PubMed ID: 8115204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the prevention of coronary heart disease: screening of children and adolescents for high blood cholesterol.
    Reece SM
    Nurse Pract; 1995 Feb; 20(2):22, 24-6, 31 passim. PubMed ID: 7715864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric cholesterol screening: missed opportunities.
    Liacouras CA; Shamir R
    Isr J Med Sci; 1997 Oct; 33(10):659-62. PubMed ID: 9397139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic.
    Stempel H; Dodge A; Marriott E; Peterson AL
    J Pediatr; 2016 Nov; 178():285-287. PubMed ID: 27592098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis and cardiovascular screening rates in the United States.
    Alamdari HS; Gustafson CJ; Davis SA; Huang W; Feldman SR
    J Drugs Dermatol; 2013 Jan; 12(1):e14-9. PubMed ID: 23377342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
    Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric guidelines for dyslipidemia.
    Daniels SR
    J Clin Lipidol; 2015; 9(5 Suppl):S5-S10. PubMed ID: 26343212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Pediatric and Adult Guidelines for Treatment of Lipid Levels Among US Adolescents Transitioning to Young Adulthood.
    Gooding HC; Rodday AM; Wong JB; Gillman MW; Lloyd-Jones DM; Leslie LK; de Ferranti SD
    JAMA Pediatr; 2015 Jun; 169(6):569-74. PubMed ID: 25845026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercholesterolemia in adolescents: effectiveness of screening strategies based on selected risk factors.
    Steiner NJ; Neinstein LS; Pennbridge J
    Pediatrics; 1991 Aug; 88(2):269-75. PubMed ID: 1861925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric urgent care.
    Tebb KP; Wibbelsman C; Neuhaus JM; Shafer MA
    Arch Pediatr Adolesc Med; 2009 Jun; 163(6):559-64. PubMed ID: 19487613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.